Document:

Exh. 10.3 - Warrant to Port dated February 15, 2006 for 250,000 shares

THIS WARRANT AND THE SHARES OF COMMON STOCK  ISSUABLE UPON EXERCISE  HEREOF HAVE
NOT  BEEN  REGISTERED  UNDER  THE  SECURITIES  ACT  OF  1933,  AS  AMENDED  (THE
"SECURITIES ACT") OR ANY STATE SECURITIES LAWS AND MAY NOT BE SOLD,  TRANSFERRED
OR OTHERWISE  DISPOSED OF UNLESS  REGISTERED  UNDER THE SECURITIES ACT AND UNDER
APPLICABLE  STATE SECURITIES LAWS OR MEDICAL MEDIA  TELEVISION,  INC. SHALL HAVE
RECEIVED  AN  OPINION  OF  COUNSEL  REASONABLY  SATISFACTORY  TO  MEDICAL  MEDIA
TELEVISION,  INC. THAT  REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT
AND UNDER THE PROVISIONS OF APPLICABLE STATE SECURITIES LAWS IS NOT REQUIRED.

                               WARRANT TO PURCHASE

                             SHARES OF COMMON STOCK

                                       OF

                         MEDICAL MEDIA TELEVISION, INC.

                            Expires February 14, 2011

                                                       Number of Shares: 250,000
Date of Issuance: February 15, 2006                    Warrant No.:     W-SP0215

         FOR VALUE  RECEIVED,  subject to the provisions  hereinafter set forth,
the undersigned, Medical Media Television, Inc., a Florida corporation (together
with its successors and assigns, the "Issuer"),  hereby certifies that Steven J.
Port,  a resident  of  California  (or his  registered  assigns)  is entitled to
subscribe  for and  purchase,  during  the Term (as  hereinafter  defined),  Two
Hundred Fifty Thousand (250,000) shares of the duly authorized,  validly issued,
fully paid and  non-assessable  Common Stock of the Issuer, at an exercise price
per share of $.75 subject,  however,  to the  provisions  and upon the terms and
conditions hereinafter set forth. Capitalized terms used in this Warrant and not
otherwise defined herein shall have the respective meanings specified in Section
9 hereof.

         1. Term.  The term of this Warrant shall  commence on February 15, 2006
and shall expire at 5:00 p.m.,  Eastern  Time, on February 14, 2011 (such period
being the "Term").

         2. Method of Exercise  Payment;  Issuance of New Warrant;  Transfer and
Exchange.

            (a)  Time of  Exercise.  The  purchase  rights  represented  by this
Warrant  may be  exercised  in whole or in part  during the Term  commencing  on
February 15, 2006 and expiring on February 14, 2011.

            (b) Method of Exercise. The Holder hereof may exercise this Warrant,
in whole or in part,  by the  surrender of this Warrant  (with the exercise form
attached hereto duly executed) at the principal office of the Issuer, and by the
payment  to the  Issuer  of an  amount of  consideration  therefor  equal to the
Warrant Price,  payable at such Holder's  election by certified or official bank
check or by wire transfer to an account designated by the Issuer.
<PAGE>

            (c) Issuance of Stock Certificates.  In the event of any exercise of
the rights  represented  by this Warrant in  accordance  with and subject to the
terms and conditions hereof, (i) certificates for the shares of Warrant Stock so
purchased  shall be dated the date of such  exercise and delivered to the Holder
hereof within a reasonable time, not exceeding three (3) Trading Days after such
exercise and the Holder hereof shall be deemed for all purposes to be the holder
of the shares of Warrant Stock so purchased as of the date of such exercise and,
unless this Warrant has expired, a new Warrant representing the number of shares
of Warrant Stock, if any, with respect to which this Warrant shall not then have
been exercised shall also be issued to the Holder hereof at the Issuer's expense
within such time.

            (d)  Transferability of Warrant.  Subject to provisions herein, this
Warrant may be  transferred  by a Holder  without the consent of the Issuer.  If
transferred  pursuant  to  this  paragraph  and  subject  to the  provisions  of
subsection  (f) of this Section 2, this Warrant may be  transferred on the books
of the Issuer by the  Holder  hereof in person or by duly  authorized  attorney,
upon surrender of this Warrant at the principal  office of the Issuer,  properly
endorsed (by the Holder executing an assignment in the form attached hereto) and
upon payment of any necessary transfer tax or other governmental  charge imposed
upon such transfer.  This Warrant is exchangeable at the principal office of the
Issuer for Warrants for the purchase of the same  aggregate  number of shares of
Warrant  Stock,  each new Warrant to represent the right to purchase such number
of shares of Warrant Stock as the Holder  hereof shall  designate at the time of
such exchange.  All Warrants  issued on transfers or exchanges shall be dated as
of the Original Issue Date and shall be identical with this Warrant except as to
the name of the Holder or the number of shares of Warrant Stock, as applicable.

            (e) Continuing Rights of Holder.  The Issuer will, at the time of or
at any time after each exercise of this Warrant,  upon the request of the Holder
hereof,  acknowledge in writing the extent, if any, of its continuing obligation
to afford to such  Holder all rights to which such Holder  shall  continue to be
entitled  after such  exercise  in  accordance  with the terms of this  Warrant,
provided  that if any such  Holder  shall  fail to make any  such  request,  the
failure shall not affect the continuing  obligation of the Issuer to afford such
rights to such Holder.

            (f) Compliance with Securities Laws.

                  (i)  The  Holder  of  this  Warrant,   by  acceptance  hereof,
acknowledges  that this Warrant or the shares of Warrant Stock to be issued upon
exercise  hereof are being acquired  solely for the Holder's own account and not
as a nominee for any other party,  and for investment,  and that the Holder will
not offer,  sell or  otherwise  dispose of this Warrant or any shares of Warrant
Stock  to be  issued  upon  exercise  hereof  except  pursuant  to an  effective
registration statement, or an exemption from registration,  under the Securities
Act and any applicable state securities laws.

                  (ii) Except as provided in paragraph (iii) below, this Warrant
and all certificates  representing  shares of Warrant Stock issued upon exercise
hereof  shall be  stamped  or  imprinted  with a  legend  in  substantially  the
following form:

                  THIS  WARRANT  AND THE SHARES OF COMMON  STOCK  ISSUABLE  UPON
                  EXERCISE HEREOF HAVE NOT BEEN REGISTERED  UNDER THE SECURITIES
                  ACT OF 1933,  AS AMENDED (THE  "SECURITIES  ACT") OR ANY STATE
                  SECURITIES LAWS AND MAY NOT BE SOLD,  TRANSFERRED OR OTHERWISE
                  DISPOSED OF UNLESS  REGISTERED  UNDER THE  SECURITIES  ACT AND
                  UNDER  APPLICABLE  STATE  SECURITIES  LAWS  OR  MEDICAL  MEDIA
                  TELEVISION,  INC.  SHALL HAVE  RECEIVED  AN OPINION OF COUNSEL
                  REASONABLY SATISFACTORY TO MEDICAL MEDIA TELEVISION, INC. THAT
                  REGISTRATION OF SUCH  SECURITIES  UNDER THE SECURITIES ACT AND
                  UNDER THE PROVISIONS OF APPLICABLE  STATE  SECURITIES  LAWS IS
                  NOT REQUIRED.

                                        2
<PAGE>

                  (iii)  The   Issuer   agrees  to  reissue   this   Warrant  or
certificates representing any of the Warrant Stock, without the legend set forth
above if at such time, prior to making any transfer of any such securities,  the
Holder shall give written  notice to the Issuer  describing the manner and terms
of such transfer and removal as the Issuer may reasonably request. Such proposed
transfer and removal will not be effected  until:  (a) either (i) the Issuer has
received an opinion of counsel  reasonably  satisfactory  to the Issuer,  to the
effect that the  registration of such securities under the Securities Act is not
required  in  connection  with  such  proposed  transfer,  (ii)  a  registration
statement  under the Securities Act covering such proposed  disposition has been
filed by the Issuer with the Securities  and Exchange  Commission and has become
effective under the Securities Act, (iii) the Issuer has received other evidence
reasonably  satisfactory to the Issuer that such  registration and qualification
under the Securities Act and state securities laws are not required, or (iv) the
Holder provides the Issuer with reasonable  assurances that such security can be
sold  pursuant  to Rule 144 under the  Securities  Act;  and (b)  either (i) the
Issuer has received an opinion of counsel reasonably satisfactory to the Issuer,
to the effect that  registration or qualification  under the securities or "blue
sky"  laws of any  state  is not  required  in  connection  with  such  proposed
disposition,  or (ii) compliance with applicable  state securities or "blue sky"
laws has been effected or a valid  exemption  exists with respect  thereto.  The
Issuer will  respond to any such notice from a holder  within five (5)  business
days. In the case of any proposed  transfer under this Section,  the Issuer will
use reasonable  efforts to comply with any such applicable  state  securities or
"blue  sky"  laws,  but  shall in no event be  required,  (x) to  qualify  to do
business  in any state  where it is not then  qualified,  (y) to take any action
that would  subject it to tax or to the general  service of process in any state
where it is not then  subject,  or (z) to comply with state  securities or "blue
sky" laws of any state for which  registration by coordination is unavailable to
the Issuer.  The restrictions on transfer  contained in this Section shall be in
addition to, and not by way of limitation of, any other restrictions on transfer
contained in any other section of this Warrant.

            (g) In no event may the Holder  exercise this Warrant in whole or in
part unless the Holder is an  "accredited  investor" as defined in  Regulation D
under the Securities Act.

         3. Stock Fully Paid; Reservation and Listing of Shares; Covenants.

            (a) Stock Fully Paid. The Issuer represents, warrants, covenants and
agrees that all shares of Warrant Stock which may be issued upon the exercise of
this Warrant or otherwise  hereunder  will,  when issued in accordance  with the
terms of this  Warrant,  be duly  authorized,  validly  issued,  fully  paid and
non-assessable  and free from all taxes, liens and charges created by or through
Issuer.  The Issuer  further  covenants and agrees that during the period within
which  this  Warrant  may be  exercised,  the  Issuer  will  at all  times  have
authorized  and  reserved  for the  purpose of the issue upon  exercise  of this
Warrant  a  sufficient  number of shares  of  Common  Stock to  provide  for the
exercise of this Warrant.

            (b)  Reservation.  If any  shares of  Common  Stock  required  to be
reserved for  issuance  upon  exercise of this Warrant or as otherwise  provided
hereunder require registration or qualification with any governmental  authority
under any federal or state law before  such shares may be so issued,  the Issuer
will in good faith use its reasonable best efforts as  expeditiously as possible
at its expense to cause such shares to be duly  registered or qualified.  If the
Issuer  shall  list any shares of Common  Stock on any  securities  exchange  or
market it will,  at its  expense,  list  thereon,  maintain  and  increase  when
necessary such listing,  of all shares of Warrant Stock from time to time issued
upon exercise of this Warrant or as otherwise provided hereunder  (provided that
such Warrant  Stock has been  registered  pursuant to a  registration  statement
under the Securities Act then in effect),  and, to the extent  permissible under
the applicable  securities  exchange rules, all unissued shares of Warrant Stock
which are at any time issuable hereunder,  so long as any shares of Common Stock
shall be so listed. The Issuer will also so list on each securities  exchange or
market, and will maintain such listing of, any other securities which the Holder
of this  Warrant  shall be entitled to receive upon the exercise of this Warrant
if at the time  any  securities  of the  same  class  shall  be  listed  on such
securities exchange or market by the Issuer.

                                        3
<PAGE>

            (c) Covenants. The Issuer shall not by any action including, without
limitation, amending the Articles of Incorporation or the by-laws of the Issuer,
or  through  any  reorganization,  transfer  of assets,  consolidation,  merger,
dissolution,  issue or sale of securities or any other action,  avoid or seek to
avoid the  observance or  performance  of any of the terms of this Warrant,  but
will at all times in good faith assist in the carrying out of all such terms and
in the taking of all such actions as may be necessary or  appropriate to protect
the rights of the Holder  hereof  against  dilution (to the extent  specifically
provided  herein)  or  impairment.   Without  limiting  the  generality  of  the
foregoing,  the Issuer will (i) not permit the par value,  if any, of its Common
Stock to exceed the then effective  Warrant Price,  (ii) not amend or modify any
provision  of the  Articles  of  Incorporation  or  by-laws of the Issuer in any
manner that would adversely  affect the rights of the Holders of the Warrants in
their capacity as Holders of the Warrants,  (iii) take all such action as may be
reasonably  necessary  in order that the Issuer may validly  and  legally  issue
fully  paid and  nonassessable  shares  of Common  Stock,  free and clear of any
liens,  claims,  encumbrances and  restrictions  (other than as provided herein)
upon the exercise of this Warrant,  and (iv) use its reasonable  best efforts to
obtain  all  such  authorizations,   exemptions  or  consents  from  any  public
regulatory body having  jurisdiction  thereof as may be reasonably  necessary to
enable the Issuer to perform its obligations under this Warrant.

            (d) Loss, Theft,  Destruction of Warrants.  Upon receipt of evidence
satisfactory to the Issuer of the ownership of and the loss, theft,  destruction
or  mutilation  of any  Warrant  and,  in the  case of any such  loss,  theft or
destruction,  upon receipt of indemnity or security  satisfactory  to the Issuer
or, in the case of any such mutilation,  upon surrender and cancellation of such
Warrant,  the  Issuer  will  make and  deliver,  in lieu of such  lost,  stolen,
destroyed or mutilated Warrant, a new Warrant of like tenor and representing the
right to purchase the same number of shares of Common Stock.

         4. Adjustment of Warrant Price and Warrant Share Number.  The number of
shares of Common Stock for which this Warrant is  exercisable,  and the price at
which such  shares may be  purchased  upon  exercise of this  Warrant,  shall be
subject  to  adjustment  from time to time as set forth in this  Section  4. The
Issuer shall give the Holder notice of any event  described below which requires
an adjustment pursuant to this Section 4 in accordance with Section 5.

            (a)     Recapitalization,      Reorganization,     Reclassification,
Consolidation, Merger or Sale.

                  (i) In case the Issuer after the Original  Issue Date shall do
any of the following (each, a "Triggering Event"): (a) consolidate or merge with
or into another  corporation where the holders of outstanding Voting Stock prior
to such merger or  consolidation  do not own over 50% of the outstanding  Voting
Stock of the merged or  consolidated  entity  immediately  after such  merger or
consolidation,  or (b) sell all or substantially all of its properties or assets
to any other  Person,  or (c) change the Common  Stock to the same or  different
number of shares of any class or classes of stock,  whether by reclassification,
exchange,  substitution  or  otherwise  (other  than by way of a stock  split or
combination  of shares  or stock  dividends  or  distributions  provided  for in
Section 4(b) or Section  4(c)),  or (d) effect a capital  reorganization  (other
than by way of a stock  split or  combination  of shares or stock  dividends  or
distributions  provided for in Section 4(b) or Section  4(c)),  then, and in the
case of each such Triggering Event, proper provision shall be made so that, upon
the basis and the terms and in the manner  provided in this Warrant,  the Holder
of this Warrant shall be entitled upon the exercise hereof at any time after the
consummation  of such  Triggering  Event,  to the  extent  this  Warrant  is not
exercised  prior to such  Triggering  Event,  to receive at the Warrant Price in
effect at the time  immediately  prior to the  consummation  of such  Triggering
Event in lieu of the Common Stock  issuable  upon such  exercise of this Warrant
prior to such Triggering Event, the securities,  cash and property to which such
Holder would have been entitled upon the  consummation of such Triggering  Event
if such Holder had exercised the rights represented by this Warrant  immediately
prior thereto,  subject to adjustments  (subsequent to such corporate action) as
nearly equivalent as possible to the adjustments  provided for elsewhere in this
Section 4.

                                        4
<PAGE>

                  (ii) Notwithstanding anything contained in this Warrant to the
contrary,  a Triggering  Event shall not be deemed to have occurred if, prior to
the  consummation  thereof,  each Person  (other  than the Issuer)  which may be
required to deliver any  securities,  cash or property upon the exercise of this
Warrant as provided herein shall assume, by written instrument delivered to, and
reasonably  satisfactory to, the Holder of this Warrant,  (A) the obligations of
the Issuer under this Warrant (and if the Issuer shall survive the  consummation
of such Triggering Event, such assumption shall be in addition to, and shall not
release the Issuer from,  any  continuing  obligations  of the Issuer under this
Warrant)  and (B) the  obligation  to  deliver  to such  Holder  such  shares of
securities,  cash or property as, in accordance with the foregoing provisions of
this subsection  (a), such Holder shall be entitled to receive,  and such Person
shall have similarly delivered to such Holder a written acknowledgement executed
by the President or Chief  Financial  Officer of the Company,  stating that this
Warrant shall thereafter  continue in full force and effect and the terms hereof
(including,  without  limitation,  all of the provisions of this subsection (a))
shall be applicable to the securities, cash or property which such Person may be
required to deliver  upon any  exercise of this  Warrant or the  exercise of any
rights pursuant hereto.

            (b) Stock Dividends,  Subdivisions and Combinations.  If at any time
the Issuer shall:

                  (i) make or issue or set a record  date for the holders of its
Common Stock for the purpose of entitling them to receive a dividend payable in,
or other distribution of, shares of Common Stock,

                  (ii) effect a stock split of its outstanding  shares of Common
Stock into a larger number of shares of Common Stock, or

                  (iii)  combine its  outstanding  shares of Common Stock into a
smaller number of shares of Common Stock,

then (1) the  number  of  shares of Common  Stock  for  which  this  Warrant  is
exercisable immediately after the occurrence of any such event shall be adjusted
to equal the number of shares of Common Stock which a record  holder of the same
number of  shares  of  Common  Stock  for  which  this  Warrant  is  exercisable
immediately  prior to the  occurrence  of such event would own or be entitled to
receive  after the  happening of such event,  and (2) the Warrant  Price then in
effect  shall  be  adjusted  to  equal  (A) the  Warrant  Price  then in  effect
multiplied  by the number of shares of Common  Stock for which  this  Warrant is
exercisable  immediately  prior to the  adjustment  divided by (B) the number of
shares of Common Stock for which this Warrant is exercisable  immediately  after
such adjustment.

                                        5
<PAGE>

Notwithstanding  the  foregoing,  if such  record date shall have been fixed and
such dividend is not fully paid or if such distribution is not fully made on the
date fixed  therefor,  the  Warrant  Price  shall be  adjusted  pursuant to this
paragraph as of the time of actual payment of such dividends or distributions.

            (c) Certain  Other  Distributions.  If at any time the Issuer  shall
make or issue or set a record date for the  determination  of the holders of its
Common Stock for the purpose of entitling  them to receive any dividend or other
distribution of:

                  (i) cash (other than a cash  dividend  payable out of earnings
or earned surplus legally  available for the payment of dividends under the laws
of the jurisdiction of incorporation of the Issuer),

                  (ii) any evidences of its indebtedness, any shares of stock of
any class or any other  securities or property of any nature  whatsoever  (other
than cash, Common Stock Equivalents or Additional Shares of Common Stock), or

                  (iii)  any  warrants  or  other  rights  to  subscribe  for or
purchase any evidences of its indebtedness,  any shares of stock of any class or
any other  securities  or  property of any nature  whatsoever  (other than cash,
Common Stock Equivalents or Additional Shares of Common Stock),

then (1) the  number  of  shares of Common  Stock  for  which  this  Warrant  is
exercisable  shall be  adjusted  to equal the product of the number of shares of
Common Stock for which this  Warrant is  exercisable  immediately  prior to such
adjustment  multiplied by a fraction (A) the numerator of which shall be the Per
Share Market Value of Common Stock at the date of taking such record and (B) the
denominator  of which  shall be such Per Share  Market  Value  minus the  amount
allocable to one share of Common Stock of any such cash so distributable  and of
the fair value (as  determined  in good faith by the Board of  Directors  of the
Issuer and supported by an opinion from an investment banking firm of recognized
national standing acceptable to (but not affiliated with) the Holder) of any and
all such  evidences  of  indebtedness,  shares of  stock,  other  securities  or
property or warrants or other  subscription or purchase rights so distributable,
and (2) the  Warrant  Price then in effect  shall be  adjusted  to equal (A) the
Warrant Price then in effect  multiplied by the number of shares of Common Stock
for which  this  Warrant  is  exercisable  immediately  prior to the  adjustment
divided  by (B) the number of shares of Common  Stock for which this  Warrant is
exercisable immediately after such adjustment.  A reclassification of the Common
Stock  (other  than a change in par value,  or from par value to no par value or
from no par value to par value)  into  shares of Common  Stock and shares of any
other class of stock shall be deemed a distribution by the Issuer to the holders
of its  Common  Stock of such  shares of such  other  class of stock  within the
meaning of this  Section  4(c) and, if the  outstanding  shares of Common  Stock
shall be changed into a larger or smaller  number of shares of Common Stock as a
part of such  reclassification,  such change  shall be deemed a  subdivision  or
combination,  as the case may be, of the  outstanding  shares  of  Common  Stock
within the meaning of Section 4(b).

Notwithstanding  the  foregoing,  if such  record date shall have been fixed and
such dividend is not fully paid or if such distribution is not fully made on the
date fixed  therefor,  the  Warrant  Price  shall be  adjusted  pursuant to this
Section  4(d)  as  of  the  time  of  actual   payment  of  such   dividends  or
distributions.

                                        6
<PAGE>

            (d)  Purchase of Common  Stock by the  Issuer.  If the Issuer at any
time while this Warrant is outstanding  shall,  directly or indirectly through a
Subsidiary or  otherwise,  purchase,  redeem or otherwise  acquire any shares of
Common Stock at a price per share greater than the Per Share Market Value,  then
the Warrant Price upon each such purchase,  redemption or  acquisition  shall be
adjusted  to that  price  determined  by  multiplying  such  Warrant  Price by a
fraction (i) the numerator of which shall be the number of shares of Outstanding
Common Stock immediately prior to such purchase, redemption or acquisition minus
the number of shares of Common Stock which the aggregate  consideration  for the
total number of such shares of Common Stock so  purchased,  redeemed or acquired
would purchase at the Per Share Market Value;  and (ii) the denominator of which
shall be the number of shares of Outstanding Common Stock immediately after such
purchase,  redemption or acquisition.  For the purposes of this subsection,  the
date as of which the Per  Share  Market  Price  shall be  computed  shall be the
earlier of (x) the date on which the Issuer shall enter into a firm contract for
the purchase, redemption or acquisition of such Common Stock, or (y) the date of
actual  purchase,  redemption  or  acquisition  of such  Common  Stock.  For the
purposes of this subsection,  a purchase,  redemption or acquisition of a Common
Stock  Equivalent  shall be deemed to be a  purchase  of the  underlying  Common
Stock,  and the  computation  herein  required shall be made on the basis of the
full  exercise,  conversion  or exchange of such Common Stock  Equivalent on the
date as of which such computation is required hereby to be made,  whether or not
such  Common  Stock   Equivalent  is  actually   exercisable,   convertible   or
exchangeable on such date.

            (e) Other Provisions  applicable to Adjustments  under this Section.
The following provisions shall be applicable to the making of adjustments of the
number of shares of Common Stock for which this Warrant is  exercisable  and the
Warrant Price then in effect provided for in this Section 4:

                  (i) Fractional Interests.  In computing adjustments under this
Section 4,  fractional  interests in Common Stock shall be taken into account to
the nearest one one-hundredth (1/100th) of a share.

                  (ii) When Adjustment Not Required.  If the Issuer shall take a
record of the holders of its Common Stock for the purpose of  entitling  them to
receive a dividend or distribution or subscription or purchase rights and shall,
thereafter and before the distribution to stockholders thereof,  legally abandon
its plan to pay or deliver such dividend, distribution, subscription or purchase
rights,  then thereafter no adjustment shall be required by reason of the taking
of such record and any such adjustment  previously made in respect thereof shall
be rescinded and annulled.

            (f) Form of Warrant after Adjustments. The form of this Warrant need
not be changed because of any adjustments in the Warrant Price or the number and
kind of Securities purchasable upon the exercise of this Warrant.

            (g)  Escrow  of  Warrant  Stock.  If  after  any  property   becomes
distributable  pursuant to this  Section 4 by reason of the taking of any record
of the holders of Common  Stock,  but prior to the  occurrence  of the event for
which such record is taken, and the Holder exercises this Warrant, any shares of
Common Stock issuable upon exercise by reason of such adjustment shall be deemed
the  last  shares  of  Common   Stock  for  which  this   Warrant  is  exercised
(notwithstanding  any other provision to the contrary herein) and such shares or
other property shall be held in escrow for the Holder by the Issuer to be issued
to the Holder upon and to the extent that the event actually  takes place,  upon
payment of the current Warrant Price. Notwithstanding any other provision to the
contrary herein,  if the event for which such record was taken fails to occur or
is  rescinded,  then such  escrowed  shares shall be cancelled by the Issuer and
escrowed property returned.

                                        7
<PAGE>

         5. Notice of  Adjustments.  Whenever the Warrant Price or Warrant Share
Number  shall be adjusted  pursuant  to Section 4 hereof  (for  purposes of this
Section 5, each an  "adjustment"),  the Issuer  shall cause its Chief  Financial
Officer to prepare  and  execute a  certificate  setting  forth,  in  reasonable
detail,  the event requiring the adjustment,  the amount of the adjustment,  the
method by which such  adjustment was calculated  (including a description of the
basis on which the Board  made any  determination  hereunder),  and the  Warrant
Price and Warrant Share Number after giving effect to such adjustment, and shall
cause copies of such  certificate  to be delivered to the Holder of this Warrant
promptly after each adjustment. Any dispute between the Issuer and the Holder of
this Warrant with  respect to the matters set forth in such  certificate  may at
the option of the Holder of this  Warrant be  submitted  to one of the  national
accounting  firms  currently  known as the "big four"  selected  by the  Holder,
provided  that the Issuer shall have ten (10) days after  receipt of notice from
such Holder of its selection of such firm to object thereto,  in which case such
Holder shall select another such firm and the Issuer shall have no such right of
objection.  The firm  selected by the Holder of this  Warrant as provided in the
preceding  sentence shall be instructed to deliver a written  opinion as to such
matters to the Issuer and such Holder within  thirty (30) days after  submission
to it of such  dispute.  Such opinion  shall be final and binding on the parties
hereto.

         6.  Fractional  Shares.  No fractional  shares of Warrant Stock will be
issued in connection  with any exercise  hereof,  but in lieu of such fractional
shares,  the Issuer  shall make a cash payment  therefor  equal in amount to the
product of the applicable fraction multiplied by the Per Share Market Value then
in effect.

         7.  Ownership Cap and Certain Exercise Restrictions.

            (a)  Notwithstanding  anything  to the  contrary  set  forth in this
Warrant,  at no time may a Holder of this Warrant  exercise  this Warrant if the
number of shares of Common Stock to be issued  pursuant to such  exercise  would
exceed,  when  aggregated  with all other  shares of Common  Stock owned by such
Holder at such time,  the number of shares of Common Stock which would result in
such Holder  owning more than 4.999% of all of the Common Stock  outstanding  at
such time; provided,  however,  that upon a holder of this Warrant providing the
Issuer with  sixty-one  (61) days notice  (pursuant  to Section 13 hereof)  (the
"Waiver  Notice")  that such Holder  would like to waive this  Section 7(a) with
regard to any or all  shares of Common  Stock  issuable  upon  exercise  of this
Warrant, this Section 7(a) will be of no force or effect with regard to all or a
portion of the Warrant referenced in the Waiver Notice; provided,  further, that
this provision  shall be of no further force or effect during the sixty-one (61)
days immediately preceding the expiration of the term of this Warrant.

            (b) The Holder may not exercise the Warrant  hereunder to the extent
such exercise would result in the Holder  beneficially  owning (as determined in
accordance  with Section 13(d) of the Exchange Act and the rules  thereunder) in
excess of 9.999% of the then  issued  and  outstanding  shares of Common  Stock,
including  shares issuable upon exercise of the Warrant held by the Holder after
application  of this  Section;  provided,  however,  that  upon a holder of this
Warrant  providing  the Company with a Waiver Notice that such holder would like
to waive this  Section  7(b) with  regard to any or all  shares of Common  Stock
issuable upon  exercise of this Warrant,  this Section 7(b) shall be of no force
or effect with regard to those shares of Warrant Stock  referenced in the Waiver
Notice;  provided,  further, that this provision shall be of no further force or
effect during the sixty-one  (61) days  immediately  preceding the expiration of
the term of this Warrant.

         8.  Registration  Rights.  The  shares of Common  Stock  issuable  upon
exercise of this Warrant shall have standard "piggyback" registration rights.

         9.  Definitions.  For the purposes of this Warrant, the following terms
have the following meanings:

                  "Articles   of   Incorporation"    means   the   Articles   of
         Incorporation  of the Issuer as in effect on the  Original  Issue Date,
         and as hereafter from time to time amended,  modified,  supplemented or
         restated in  accordance  with the terms hereof and thereof and pursuant
         to applicable law.

                  "Board" shall mean the Board of Directors of the Issuer.

                                        8
<PAGE>

                  "Capital  Stock"  means and  includes  (i) any and all shares,
         interests,  participations  or other  equivalents  of or  interests  in
         (however designated)  corporate stock,  including,  without limitation,
         shares of preferred or preference stock, (ii) all partnership interests
         (whether  general or  limited)  in any Person  which is a  partnership,
         (iii) all membership  interests or limited  liability company interests
         in any  limited  liability  company,  and (iv) all equity or  ownership
         interests in any Person of any other type.

                  "Common  Stock" means the Common  Stock,  par value $.0005 per
         share,  of the Issuer and any other Capital Stock into which such stock
         may hereafter be changed.

                  "Convertible  Securities"  means  evidences  of  Indebtedness,
         shares of Capital Stock or other  Securities which are or may be at any
         time convertible  into or exchangeable for Additional  Shares of Common
         Stock.  The term  "Convertible  Security"  means one of the Convertible
         Securities.

                  "Governmental Authority" means any governmental, regulatory or
         self-regulatory   entity,   department,   body,  official,   authority,
         commission, board, agency or instrumentality, whether federal, state or
         local, and whether domestic or foreign.

                  "Holders" mean the Persons who shall from time to time own any
         Warrant. The term "Holder" means one of the Holders.

                  "Independent Appraiser" means a nationally recognized or major
         regional  investment  banking  firm or firm  of  independent  certified
         public  accountants of recognized  standing (which may be the firm that
         regularly  examines  the  financial  statements  of the Issuer) that is
         regularly  engaged in the business of  appraising  the Capital Stock or
         assets of corporations  or other entities as going concerns,  and which
         is not affiliated with either the Issuer or the Holder of any Warrant.

                  "Issuer"  means  Medical  Media  Television, Inc.,  a  Florida
         corporation, and its successors.

                  "Majority  Holders"  means at any time the Holders of Warrants
         exercisable  for a majority  of the shares of  Warrant  Stock  issuable
         under the Warrants at the time outstanding.

                  "Original Issue Date" means February 15, 2006.

                  "OTC  Bulletin  Board" means the  over-the-counter  electronic
         bulletin board.

                  "Other  Common" means any other Capital Stock of the Issuer of
         any class which shall be  authorized at any time after the date of this
         Warrant  (other  than  Common  Stock) and which shall have the right to
         participate  in the  distribution  of earnings and assets of the Issuer
         without limitation as to amount.

                  "Outstanding  Common  Stock"  means,  at any given  time,  the
         aggregate amount of outstanding  shares of Common Stock,  assuming full
         exercise,  conversion  or  exchange  (as  applicable)  of all  options,
         warrants and other Securities which are convertible into or exercisable
         or  exchangeable  for, and any right to subscribe for, shares of Common
         Stock that are outstanding at such time.

                  "Person" means an individual,  corporation,  limited liability
         company,  partnership,   joint  stock  company,  trust,  unincorporated
         organization,  joint venture, Governmental Authority or other entity of
         whatever nature.

                                        9
<PAGE>

                  "Per Share Market Value" means on any particular  date (a) the
         closing bid price for a share of Common  Stock in the  over-the-counter
         market,  as  reported  by the OTC  Bulletin  Board  or in the  National
         Quotation  Bureau  Incorporated  or  similar   organization  or  agency
         succeeding  to its  functions  of  reporting  prices)  at the  close of
         business on such date,  or (b) if the Common Stock is not then reported
         by the OTC Bulletin Board or the National Quotation Bureau Incorporated
         (or similar  organization  or agency  succeeding  to its  functions  of
         reporting prices),  then the average of the "Pink Sheet" quotes for the
         relevant  conversion period, as determined in good faith by the holder,
         or (c) if the Common Stock is not then publicly  traded the fair market
         value of a share of  Common  Stock as  determined  by the Board in good
         faith;  provided,  however, that the Majority Holders, after receipt of
         the determination by the Board, shall have the right to select, jointly
         with the Issuer,  an  Independent  Appraiser,  in which case,  the fair
         market value shall be the determination by such Independent  Appraiser;
         and provided,  further that all  determinations of the Per Share Market
         Value shall be appropriately  adjusted for any stock  dividends,  stock
         splits  or  other  similar   transactions   during  such  period.   The
         determination  of fair market value shall be based upon the fair market
         value of the Issuer  determined  on a going  concern basis as between a
         willing buyer and a willing seller and taking into account all relevant
         factors  determinative  of value, and shall be final and binding on all
         parties.  In determining  the fair market value of any shares of Common
         Stock, no consideration  shall be given to any restrictions on transfer
         of the  Common  Stock  imposed  by  agreement  or by  federal  or state
         securities  laws, or to the existence or absence of, or any limitations
         on, voting rights.

                  "Securities"  means  any  debt  or  equity  securities  of the
         Issuer, whether now or hereafter authorized, any instrument convertible
         into or  exchangeable  for  Securities  or a Security,  and any option,
         warrant or other right to purchase or acquire any Security.  "Security"
         means one of the Securities.

                  "Securities Act" means the Securities Act of 1933, as amended,
         or any similar federal statute then in effect.

                  "Subsidiary"  means  any  corporation  at  least  50% of whose
         outstanding  Voting  Stock  shall  at the  time be  owned  directly  or
         indirectly by the Issuer or by one or more of its  Subsidiaries,  or by
         the Issuer and one or more of its Subsidiaries.

                  "Term" has the meaning specified in Section 1 hereof.

                  "Trading  Day"  means (a) a day on which the  Common  Stock is
         traded on the OTC  Bulletin  Board,  or (b) if the Common  Stock is not
         traded on the OTC  Bulletin  Board,  a day on which the Common Stock is
         quoted in the  over-the-counter  market  as  reported  by the  National
         Quotation Bureau  Incorporated  (or any similar  organization or agency
         succeeding its functions of reporting prices); provided,  however, that
         in the event that the Common Stock is not listed or quoted as set forth
         in (a) or (b)  hereof,  then  Trading  Day  shall  mean any day  except
         Saturday, Sunday and any day which shall be a legal holiday or a day on
         which banking  institutions  in the State of New York are authorized or
         required by law or other government action to close.

                  "Voting  Stock" means,  as applied to the Capital Stock of any
         corporation, Capital Stock of any class or classes (however designated)
         having  ordinary  voting  power for the  election  of a majority of the
         members of the Board of  Directors  (or other  governing  body) of such
         corporation,  other than Capital Stock having such power only by reason
         of the happening of a contingency.

                                       10
<PAGE>

                  "Warrants" means this Warrant,  and any other warrants of like
         tenor issued in  substitution  or exchange for any thereof  pursuant to
         the  provisions of Section 2(c),  2(d) or 2(e) hereof or of any of such
         other Warrants.

                  "Warrant  Price"  initially  means U.S.  $.75, as such Warrant
         Price  may be  adjusted  from  time to time as  shall  result  from the
         adjustments specified in this Warrant, including Section 4 hereto.

                  "Warrant Share Number" means at any time the aggregate  number
         of shares of Warrant  Stock  which may at such time be  purchased  upon
         exercise of this Warrant,  after giving effect to all prior adjustments
         and  increases  to such  number  made or  required to be made under the
         terms hereof.

                  "Warrant  Stock" means Common Stock  issuable upon exercise of
         any Warrant or Warrants or otherwise  issuable  pursuant to any Warrant
         or Warrants.

         10. Other Notices. In case at any time:

                        (A)   the  Issuer  shall make any  distributions  to the
                              holders of Common Stock; or

                        (B)   the Issuer  shall  authorize  the  granting to all
                              holders of its Common Stock of rights to subscribe
                              for or purchase any shares of Capital Stock of any
                              class or other rights; or

                        (C)   there shall be any reclassification of the Capital
                              Stock of the Issuer; or

                        (D)   there shall be any capital  reorganization  by the
                              Issuer; or

                        (E)   there  shall be any (i)  consolidation  or  merger
                              involving  the  Issuer or (ii) sale,  transfer  or
                              other  disposition of all or substantially  all of
                              the Issuer's property,  assets or business (except
                              a merger  or  other  reorganization  in which  the
                              Issuer shall be the surviving  corporation and its
                              shares  of  Capital  Stock  shall  continue  to be
                              outstanding    and    unchanged   and   except   a
                              consolidation,  merger,  sale,  transfer  or other
                              disposition involving a wholly-owned  Subsidiary);
                              or

                        (F)   there   shall  be  a  voluntary   or   involuntary
                              dissolution,  liquidation  or  winding-up  of  the
                              Issuer or any partial liquidation of the Issuer or
                              distribution to holders of Common Stock;

then, in each of such cases,  the Issuer shall give written notice to the Holder
of the date on which (i) the books of the Issuer  shall close or a record  shall
be taken for such dividend,  distribution  or  subscription  rights or (ii) such
reorganization,    reclassification,    consolidation,    merger,   disposition,
dissolution,  liquidation or  winding-up,  as the case may be, shall take place.
Such notice also shall  specify the date as of which the holders of Common Stock
of record shall  participate  in such  dividend,  distribution  or  subscription
rights, or shall be entitled to exchange their certificates for Common Stock for
securities   or   other   property   deliverable   upon   such   reorganization,
reclassification,  consolidation, merger, disposition,  dissolution, liquidation
or  winding-up,  as the case may be. Such notice  shall be given at least twenty
(20) days prior to the record date or effective date for the event  specified in
such notice.

                                       11
<PAGE>

         11. Amendment and Waiver. Any term, covenant, agreement or condition in
this  Warrant may be amended,  or  compliance  therewith  may be waived  (either
generally   or  in  a   particular   instance   and  either   retroactively   or
prospectively),  by a written instrument or written instruments  executed by the
Issuer and the Majority Holders;  provided,  however,  that no such amendment or
waiver  shall  reduce the Warrant  Share  Number,  increase  the Warrant  Price,
shorten the period  during  which this  Warrant may be  exercised  or modify any
provision of this Section 11 without the consent of the Holder of this Warrant.

         12.  Governing  Law. THIS WARRANT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE  WITH THE LAWS OF THE  STATE OF  FLORIDA,  WITHOUT  GIVING  EFFECT TO
PRINCIPLES OF CONFLICTS OF LAW.

         13. Notices.  Any and all notices or other communications or deliveries
required or permitted to be provided  hereunder shall be in writing and shall be
deemed given and  effective on the earlier of (i) the date of  transmission,  if
such  notice or  communication  is  delivered  via  facsimile  at the  facsimile
telephone  number  specified  for notice prior to 5:00 p.m.,  eastern time, on a
Trading Day, (ii) the Trading Day after the date of transmission, if such notice
or  communication  is delivered via facsimile at the facsimile  telephone number
specified for notice later than 5:00 p.m., eastern time, on any date and earlier
than 11:59 p.m., eastern time, on such date, (iii) the Trading Day following the
date  of  mailing,  if sent  by  overnight  delivery  by  nationally  recognized
overnight  courier  service  or (iv)  actual  receipt  by the party to whom such
notice is required to be given. The addresses for such  communications  shall be
with respect to the Holder of this Warrant or of Warrant  Stock issued  pursuant
hereto,  addressed to such Holder at its last known address or facsimile  number
appearing  on the books of the  Issuer  maintained  for such  purposes,  or with
respect to the Issuer, addressed to:

                           Medical Media Television, Inc.
                           8406 Benjamin Road, Suite C
                           Tampa, Florida 33634
                           Attention: Philip M. Cohen, President and CEO
                           Tel. No.: (813) 888-7330
                           Fax No.:  (813) 888-7375

Copies of  notices  to the Issuer  shall be sent to Bush Ross  Gardner  Warren &
Rudy, P.A., Attn: John N. Giordano, 220 S. Franklin Street, Tampa, FL 33601, Tel
No. (813)  224-9255,  Fax. No. (813)  224-9230.  Copies of notices to the Holder
shall be sent to Steven J. Port, 4911 Edgerton  Avenue,  Encino,  CA 91436.  Any
party  hereto may from time to time  change its address for notices by giving at
least ten (10) days written  notice of such  changed  address to the other party
hereto.

         14. Warrant Agent.  The Issuer may, by written notice to each Holder of
this  Warrant,  appoint  an agent  having an office  in Tampa,  Florida  for the
purpose  of issuing  shares of Warrant  Stock on the  exercise  of this  Warrant
pursuant to subsection (b) of Section 2 hereof, exchanging this Warrant pursuant
to  subsection  (d) of Section 2 hereof or replacing  this  Warrant  pursuant to
subsection (d) of Section 3 hereof, or any of the foregoing,  and thereafter any
such  issuance,  exchange or  replacement,  as the case may be, shall be made at
such office by such agent.

         15.  Remedies.  The Issuer  stipulates  that the remedies at law of the
Holder of this Warrant in the event of any default or threatened  default by the
Issuer in the performance of or compliance with any of the terms of this Warrant
are not and will not be adequate and that,  to the fullest  extent  permitted by
law,  such  terms may be  specifically  enforced  by a decree  for the  specific
performance  of any agreement  contained  herein or by an  injunction  against a
violation of any of the terms hereof or otherwise.

                                       12
<PAGE>

         16.  Successors  and  Assigns.  This  Warrant and the rights  evidenced
hereby  shall inure to the  benefit of and be binding  upon the  successors  and
assigns of the Issuer, the Holder hereof and (to the extent provided herein) the
Holders of Warrant Stock issued pursuant hereto, and shall be enforceable by any
such Holder or Holder of Warrant Stock.

         17.  Modification and Severability.  If, in any action before any court
or agency  legally  empowered to enforce any  provision  contained  herein,  any
provision  hereof is found to be  unenforceable,  then such  provision  shall be
deemed modified to the extent  necessary to make it enforceable by such court or
agency.  If any such provision is not  enforceable as set forth in the preceding
sentence,  the  unenforceability  of such  provision  shall not affect the other
provisions  of this  Warrant,  but this  Warrant  shall be  construed as if such
unenforceable provision had never been contained herein.

         18.  Headings.  The  headings of the  Sections of this  Warrant are for
convenience of reference  only and shall not, for any purpose,  be deemed a part
of this Warrant.

         IN WITNESS WHEREOF,  the Issuer has executed this Warrant as of the day
and year first above written.

                                   MEDICAL MEDIA TELEVISION, INC.

                                   By: /s/ Philip M. Cohen
                                       -----------------------------------------
                                           Philip M. Cohen
                                           President and Chief Executive Officer

                                       13
<PAGE>

                                  EXERCISE FORM

                         MEDICAL MEDIA TELEVISION, INC.

The  undersigned  _______________,  pursuant  to the  provisions  of the  within
Warrant, hereby elects to purchase _____ shares of Common Stock of Medical Media
Television, Inc. covered by the within Warrant.

Dated:                              Signature
       -----------------                      ----------------------------------

                                    Address
                                              ----------------------------------
                                              ----------------------------------

Number of shares of Common Stock beneficially owned or deemed beneficially owned
by the Holder on the date of Exercise: _________________________

                                   ASSIGNMENT

FOR VALUE RECEIVED,  _________________  hereby sells, assigns and transfers unto
__________________  the within Warrant and all rights evidenced thereby and does
irrevocably constitute and appoint _____________, attorney, to transfer the said
Warrant on the books of the within named corporation.

Dated:                              Signature
       -----------------                      ----------------------------------

                                    Address
                                              ----------------------------------
                                              ----------------------------------

                               PARTIAL ASSIGNMENT

FOR VALUE RECEIVED,  _________________  hereby sells, assigns and transfers unto
__________________  the right to  purchase  _________  shares of  Warrant  Stock
evidenced  by the within  Warrant  together  with all rights  therein,  and does
irrevocably  constitute and appoint  ___________________,  attorney, to transfer
that part of the said Warrant on the books of the within named corporation.

Dated:                              Signature
       -----------------                      ----------------------------------

                                    Address
                                              ----------------------------------
                                              ----------------------------------

                           FOR USE BY THE ISSUER ONLY:

This Warrant No. W-___ canceled (or  transferred or exchanged) this _____ day of
___________,  _____,  shares  of Common  Stock  issued  therefor  in the name of
_______________,  Warrant No.  W-_____ issued for ____ shares of Common Stock in
the name of _______________.Exh. 10.4-Note Purchase Agreement with Ross dated February 15, 2006

THIS NOTE  PURCHASE  AGREEMENT IS BEING ISSUED TO GILBERT B. ROSS AS A CARVE OUT
FROM THE NOTE PURCHASE  AGREEMENT  BETWEEN  MEDICAL MEDIA  TELEVISION,  INC. AND
CAPITALSMART,  LLC ("CAPITALSMART  NOTE PURCHASE  AGREEMENT") DATED FEBRUARY 14,
2006.  PER AN  AGREEMENT  BETWEEN  THE  PRINCIPALS  OF  CAPITALSMART,  LLC,  THE
CAPITALSMART NOTE PURCHASE  AGREEMENT WAS CANCELLED AND INDIVIDUAL NOTE PURCHASE
AGREEMENTS  WERE ISSUED IN LIEU  THEREOF,  EACH IN THE NAME OF A  PRINCIPAL  (OR
ENTITY CONTROLLED BY A PRINCIPAL) OF CAPITALSMART.

                             NOTE PURCHASE AGREEMENT

         This NOTE PURCHASE AGREEMENT (this  "Agreement"),  dated as of February
15, 2006, is entered into by and among Medical Media Television, Inc., a Florida
corporation  (the  "Company"),  and Gilbert B. Ross, a California  resident (the
"Purchaser"), for the issuance and sale to the Purchaser of the Note (as defined
below)  of the  Company,  in the  manner,  and upon the  terms,  provisions  and
conditions set forth in this Agreement.

         WHEREAS,  the parties  desire  that,  upon the terms and subject to the
conditions  contained herein,  the Company shall issue and sell to the Purchaser
and the Purchaser shall purchase the Note;

         WHEREAS,  such  issuance  and sale  will be made in  reliance  upon the
provisions of Section 4(2) and/or Rule 506 of Regulation D  ("Regulation  D") of
the  United  States  Securities  Act  of  1933,  as  amended,   and  regulations
promulgated thereunder (the "Securities Act"), or upon such other exemption from
the  registration  requirements  of the  Securities Act as may be available with
respect to the purchase of the Note to be made hereunder.

         NOW, THEREFORE, in consideration of the representations, warranties and
agreements  contained  herein and other  good and  valuable  consideration,  the
receipt and legal adequacy of which is hereby  acknowledged by the parties,  the
Company and the Purchaser hereby agree as follows:

         1.       Purchase and Sale of Note.

                  (a) Terms of Note: Upon the following terms and subject to the
conditions  contained herein, the Company shall issue and sell to the Purchaser,
and the Purchaser shall purchase from the Company, a convertible promissory note
in the  aggregate  principal  amount of $200,000  (the  "Purchase  Price")  made
through  installments,  in  substantially  the form attached hereto as Exhibit A
(the "Note").

         The  outstanding  principal  amount of the Note,  plus any  accrued but
unpaid interest  thereon,  shall be due and payable in cash on the Maturity Date
(as defined in the Note);  provided,  however, the Purchaser shall have the sole
option to convert on the Maturity Date the outstanding  principal  amount of the
Note plus any accrued but unpaid  interest  into such number of shares of Common
Stock of the  Company,  par value $.0005 per share (the  "Common  Stock"),  at a
Conversion  Price equal to a twenty percent (20%)  discount to the  then-current
market  price  based on the  average  closing  price  for the  twenty  (20) days
immediately preceding the conversion, but in no event shall the Conversion Price
be less than $0.166.  The Note shall not be convertible  until the Maturity Date
and shall not be  convertible  such that the  Investor's  overall  Common  Stock
ownership   position  in  the  Company   exceeds  4.99%  (the   "Ownership   Cap
Restriction"); provided, however, that upon the holder of the Note providing the
Company with  sixty-one  (61) days notice (the "Waiver  Notice") that the holder
would like to waive the  Ownership  Cap  Restriction  with  regard to any or all
shares of Common Stock issuable upon exercise of the  conversion  feature of the
Note, this Ownership Cap  Restriction  will be of no force or effect with regard
to all or a portion of the Note  referenced in the Waiver  Notice,  and provided
further that this  Ownership  Cap  Restriction  shall be of no further  force or
effect during the sixty-one  (61) days  immediately  preceding the expiration of
the term of the Note.
<PAGE>

          The Note shall bear  interest  at a rate of twenty  percent  (20%) per
annum.  Interest  shall  accrue but will not become  due and  payable  until the
Maturity Date.

         With the consent of both the Company and the Investor,  the Note may be
extended for an  additional  twelve (12) months,  with the terms of the interest
payments  remaining  the same as above.  The  Company  has the option to pay the
principal amount of this Note plus accrued but unpaid interest in a cash payment
at any time prior to the Maturity Date.

                  (b) Issuance of Warrants:  The Investor will be issued 500,000
warrants to purchase Common Stock of the Company (the "Warrants").  The Warrants
shall have a term of five (5) years and shall have an  exercise  price  equal to
$0.75 per share (the  "Exercise  Price").  The Warrants shall not be exercisable
such that the Investor's  overall Common Stock ownership position in the Company
exceeds 4.99%.

                  (c) In  consideration  of and in  express  reliance  upon  the
representations,  warranties, covenants, terms and conditions of this Agreement,
the Company  agrees to issue and sell to the Purchaser and the Purchaser  agrees
to purchase the Note.  The closing under this Agreement  (the  "Closing")  shall
take place at the offices of Medical Media Television, Inc., 8406 Benjamin Road,
Suite C, Tampa,  Florida 33634 upon the  satisfaction  of each of the conditions
set forth in Sections 4 and 5 hereof (the "Closing Date").

                  (d)  The   Investor  is  aware  that  the   Company   filed  a
Registration  Statement  on Form SB-2 which was  approved  by the  Securities  &
Exchange  Commission  on March 1, 2006 and that a total of  2,500,000  shares of
Common Stock were  reserved and  registered  for the  conversion of the original
CapitalSmart   Convertible   Promissory  Note  for   $1,000,000.   The  Investor
acknowledges  and  understands  that 500,000  shares of Common Stock  previously
registered has been allocated toward the conversion of this Note (the "Allocated
Shares") and that any shares of Common  Stock  issued to the  Investor  upon the
conversion  of this Note in excess of the  Allocated  Shares shall have standard
piggyback registration rights.

         2.  Representations,  Warranties  and Covenants of the  Purchaser.  The
Purchaser  hereby makes the  following  representations  and  warranties  to the
Company, and covenants for the benefit of the Company:

                  (a)  If  the  Purchaser  is  an  entity,  the  Purchaser  is a
corporation,  limited  liability  company or partnership  duly  incorporated  or
organized,  validly  existing  and  in  good  standing  under  the  laws  of the
jurisdiction of its incorporation or organization.

                  (b) This Agreement has been duly authorized,  validly executed
and  delivered  by the  Purchaser  and is a  valid  and  binding  agreement  and
obligation of the Purchaser enforceable against the Purchaser in accordance with
its terms, subject to limitations on enforcement by general principles of equity
and by bankruptcy or other laws affecting the  enforcement of creditors'  rights
generally, and the Purchaser has full power and authority to execute and deliver
this Agreement and the other agreements and documents contemplated hereby and to
perform its obligations hereunder and thereunder.

                                       -2-
<PAGE>

                  (c) The Purchaser understands that no Federal, state, local or
foreign  governmental  body or  regulatory  authority  has made any  finding  or
determination relating to the fairness of an investment in any of the Securities
and that no Federal,  state,  local or foreign  governmental  body or regulatory
authority  has  recommended  or  endorsed,  or will  recommend  or endorse,  any
investment in any of the  Securities.  The Purchaser,  in making the decision to
purchase the Securities,  has relied upon independent  investigation  made by it
and has not relied on any information or representations made by third parties.

                  (d) The Purchaser  understands  that the  Securities are being
offered and sold to it in reliance on specific  provisions  of Federal and state
securities  laws and that the Company is relying  upon the truth and accuracy of
the representations,  warranties, agreements, acknowledgments and understandings
of the Purchaser set forth herein for purposes of qualifying for exemptions from
registration under the Securities Act, and applicable state securities laws.

                  (e) The Purchaser is an "accredited investor" as defined under
Rule 501 of Regulation D promulgated under the Securities Act.

                  (f) The Purchaser is and will be acquiring the  Securities for
its own account,  and not with a view to any resale or  distribution of the Note
in  whole or in part,  in  violation  of the  Securities  Act or any  applicable
securities laws.

                  (g) The offer and sale of the  Securities  is  intended  to be
exempt from  registration  under the  Securities  Act, by virtue of Section 4(2)
and/or Rule 506 of  Regulation  D  promulgated  under the  Securities  Act.  The
Purchaser understands that the Securities purchased hereunder have not been, and
may  never  be,  registered  under  the  Securities  Act  and  that  none of the
Securities can be sold or transferred unless they are first registered under the
Securities Act and such state and other  securities laws as may be applicable or
in the opinion of counsel for the Company an exemption from  registration  under
the  Securities  Act is  available  (and  then  the  Securities  may be  sold or
transferred  only in compliance with such exemption and all applicable state and
other securities laws).

         3.  Representations,  Warranties  and  Covenants  of the  Company.  The
Company represents and warrants to the Purchaser,  and covenants for the benefit
of the Purchaser, as follows:

                  (a) The Company has been duly  incorporated,  validly  exists,
and is in good  standing  under  the laws of the  State of  Florida,  with  full
corporate  power and authority to own,  lease and operate its  properties and to
conduct  its  business  as  currently  conducted,  and is  duly  registered  and
qualified to conduct its business and is in good  standing in each  jurisdiction
or place  where the nature of its  properties  or the  conduct  of its  business
requires  such  registration  or  qualification,  except  where the  failure  to
register or qualify would not have a Material  Adverse  Effect.  For purposes of
this Agreement, "Material Adverse Effect" shall mean any effect on the business,
results of operations,  prospects,  assets or financial condition of the Company
that is material and adverse to the Company and its  subsidiaries and affiliates
and/or  any  condition,  circumstance,  or  situation  that  would  prohibit  or
otherwise  materially  interfere  with the ability of the Company from  entering
into and performing any of its  obligations  under this Agreement or the Note in
any material respect.

                  (b)  The  Note  has  been  duly  authorized  by all  necessary
corporate  action  and,  when paid for or issued  in  accordance  with the terms
hereof, the Note shall be validly issued and outstanding,  free and clear of all
liens,  encumbrances  and  rights of refusal  of any kind.  When the  Conversion
Shares are issued and paid for in  accordance  with the terms of this  Agreement
and as set  forth  in the  Note,  such  shares  will be duly  authorized  by all
necessary  corporate action and validly issued and  outstanding,  fully paid and
nonassessable,  free and clear of all liens,  encumbrances and rights of refusal
of any kind and the holders shall be entitled to all rights accorded to a holder
of Common Stock.

                                       -3-
<PAGE>

                  (c) The Note and this Agreement (the "Transaction  Documents")
have been duly  authorized,  validly  executed  and  delivered  on behalf of the
Company  and is a valid and  binding  agreement  and  obligation  of the Company
enforceable  against  the  Company  in  accordance  with its  terms,  subject to
limitations on enforcement by general  principles of equity and by bankruptcy or
other laws affecting the  enforcement of creditors'  rights  generally,  and the
Company has full power and  authority  to execute  and  deliver the  Transaction
Documents  and the other  agreements  and documents  contemplated  hereby and to
perform its obligations hereunder and thereunder.

                  (d) The  execution and delivery of the  Transaction  Documents
and the consummation of the  transactions  contemplated by this Agreement by the
Company,  will not (i) conflict with or result in a breach of or a default under
any  of  the  terms  or  provisions   of,  (A)  the  Company's   certificate  of
incorporation  or by-laws,  or (B) of any material  provision of any  indenture,
mortgage,  deed of trust or other material  agreement or instrument to which the
Company is a party or by which it or any of its material properties or assets is
bound, (ii) result in a violation of any material provision of any law, statute,
rule,  regulation,  or any existing applicable decree,  judgment or order by any
court,  Federal  or  state  regulatory  body,  administrative  agency,  or other
governmental body having  jurisdiction over the Company,  or any of its material
properties  or  assets or (iii)  result in the  creation  or  imposition  of any
material lien, charge or encumbrance upon any material property or assets of the
Company or any of its  subsidiaries  pursuant to the terms of any  agreement  or
instrument  to which any of them is a party or by which any of them may be bound
or to which any of their  property or any of them is subject  except in the case
of clauses (i)(B) or (iii) for any such conflicts,  breaches, or defaults or any
liens, charges, or encumbrances which would not have a Material Adverse Effect.

                  (e) The sale and issuance of the Securities in accordance with
the terms of and in reliance on the accuracy of the Purchaser's  representations
and warranties set forth in this Agreement will be exempt from the  registration
requirements of the Securities Act.

                  (f) No consent,  approval or  authorization of or designation,
declaration or filing with any governmental authority on the part of the Company
is  required  in  connection  with the  valid  execution  and  delivery  of this
Agreement or the offer,  sale or issuance of the Securities or the  consummation
of any other transaction contemplated by this Agreement.

                  (g)  There  is  no  action,  suit,  claim,   investigation  or
proceeding  pending or, to the knowledge of the Company,  threatened against the
Company  which  questions  the  validity  of the  Transaction  Documents  or the
transactions  contemplated  thereby or any action taken or to be taken  pursuant
thereto.  There is no action,  suit, claim,  investigation or proceeding pending
or, to the  knowledge  of the  Company,  threatened,  against or  involving  the
Company  or any  subsidiary,  or any of their  respective  properties  or assets
which,  if adversely  determined,  is reasonably  likely to result in a Material
Adverse Effect.

                  (h)  The  Company  has  complied  and  will  comply  with  all
applicable  federal  and state  securities  laws in  connection  with the offer,
issuance and sale of the Note  hereunder.  Neither the Company nor anyone acting
on its  behalf,  directly  or  indirectly,  has or will  sell,  offer to sell or
solicit offers to buy the Note, or similar securities to, or solicit offers with
respect   thereto  from,  or  enter  into  any  preliminary   conversations   or
negotiations  relating  thereto with, any person,  or has taken or will take any
action so as to bring the issuance  and sale of the Note under the  registration
provisions  of the  Securities  Act and any other  applicable  federal and state
securities laws.  Neither the Company nor any of its affiliates,  nor any person
acting on its or their behalf,  has engaged in any form of general  solicitation
or general  advertising (within the meaning of Regulation D under the Securities
Act) in connection with the Note.

                                       -4-
<PAGE>

                  (i) To the Company's  knowledge,  neither this Agreement,  nor
the Schedules  hereto contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the  statements  made herein or
therein,  in the light of the circumstances under which they were made herein or
therein, not misleading.

                  (j) The authorized capital stock of the Company and the shares
thereof issued and  outstanding as of January 20, 2006 are set forth on Schedule
3(j) attached  hereto.  All of the  outstanding  shares of the Common Stock have
been duly and validly authorized, and are fully paid and non-assessable.  Except
as set forth in this  Agreement or on Schedule 3(j) attached  hereto,  as of the
date hereof, no shares of the Common Stock are entitled to preemptive rights and
there are no registration rights or outstanding options, warrants, scrip, rights
to subscribe to, call or commitments of any character whatsoever relating to, or
securities  or rights  convertible  into,  any  shares of  capital  stock of the
Company.  As of the date hereof,  except for as set forth on Schedule  3(j), the
Company  is not a party to any  agreement  granting  registration  rights to any
person with respect to any of its equity or debt securities.  The Company is not
a party to, and its  executive  officers  have no  knowledge  of, any  agreement
restricting  the voting or transfer  of any shares of the  capital  stock of the
Company.  The  offer  and sale of all  capital  stock,  convertible  securities,
rights, warrants, or options of the Company issued prior to the Closing complied
with all applicable  federal and state  securities laws, or no stockholder has a
right of rescission or damages with respect  thereto which is reasonably  likely
to have a Material  Adverse Effect.  The Company has furnished or made available
to the  Purchaser  true and  correct  copies  of the  Company's  Certificate  of
Incorporation  as in  effect on the date  hereof  (the  "Certificate"),  and the
Company's Bylaws as in effect on the date hereof (the "Bylaws").

                  (k) So long as the Note remains outstanding, the Company shall
take all action necessary to at all times have authorized,  and reserved for the
purpose of issuance, a sufficient number of shares of Common Stock to effect the
conversion of the Note.

                  (l)  The  Company  has  complied  and  will  comply  with  all
applicable  federal  and state  securities  laws in  connection  with the offer,
issuance and sale of the Note and the Conversion Shares  hereunder.  Neither the
Company nor anyone  acting on its behalf,  directly or  indirectly,  has or will
sell,  offer to sell or solicit offers to buy any of the Securities,  or similar
securities  to, or solicit  offers with respect  thereto from, or enter into any
preliminary  conversations or negotiations relating thereto with, any person, or
has taken or will take any action so as to bring the issuance and sale of any of
the  Securities  under the  registration  provisions of the  Securities  Act and
applicable state securities laws. Neither the Company nor any of its affiliates,
nor any person acting on its or their behalf, has engaged in any form of general
solicitation  or general  advertising  (within the meaning of Regulation D under
the  Securities  Act)  in  connection  with  the  offer  or  sale  of any of the
Securities.

         4.  Conditions  Precedent to the  Obligation of the Company to Sell the
Note. The obligation  hereunder of the Company to issue and sell the Note to the
Purchaser  is subject to the  satisfaction  or waiver,  at or before the Closing
Date, of each of the  conditions set forth below.  These  conditions are for the
Company's  sole benefit and may be waived by the Company at any time in its sole
discretion.

                  (a) The  Purchaser  shall have  executed  and  delivered  this
Agreement.

                                       -5-
<PAGE>

                  (b) The Purchaser shall have performed, satisfied and complied
in all material respects with all covenants,  agreements and conditions required
to be performed,  satisfied or complied with by the Purchaser at or prior to the
Closing Date.

                  (c) The  representations and warranties of the Purchaser shall
be true and correct in all material  respects as of the date when made and as of
the Closing  Date as though made at that time,  except for  representations  and
warranties that are expressly made as of a particular  date, which shall be true
and correct in all material respects as of such date.

                  (d) At the Closing Date, the Purchaser shall have delivered to
the Company immediately available funds as payment in full of the Purchase Price
for the Note.

         5. Conditions  Precedent to the Obligation of the Purchaser to Purchase
the Note. The  obligation  hereunder of the Purchaser to acquire and pay for the
Note is subject to the satisfaction or waiver, at or before the Closing Date, of
each of the conditions set forth below. These conditions are for the Purchaser's
sole  benefit  and may be  waived  by the  Purchaser  at any  time  in its  sole
discretion.

                  (a) The Company  shall have  executed and  delivered the Note,
this Agreement and any other Transaction Document.

                  (b) The Company shall have  performed,  satisfied and complied
in all material respects with all covenants,  agreements and conditions required
by the Transaction Documents to be performed,  satisfied or complied with by the
Company at or prior to the Closing Date.

                  (c) Each of the  representations and warranties of the Company
shall be true and correct in all material  respects as of the date when made and
as of the Closing Date as though made at that time  (except for  representations
and  warranties  that speak as of a  particular  date),  which shall be true and
correct in all material respects as of such date.

                  (d) No statute, regulation, executive order, decree, ruling or
injunction  shall have been  enacted,  entered,  promulgated  or endorsed by any
court or governmental  authority of competent  jurisdiction  which prohibits the
consummation  of any of the  transactions  contemplated  by this Agreement at or
prior to the Closing Date.

                  (e) As of the  Closing  Date,  no action,  suit or  proceeding
before or by any court or  governmental  agency or body,  domestic  or  foreign,
shall be pending  against or affecting  the Company,  or any of its  properties,
which  questions the validity of the  Agreement,  the Note, or the  transactions
contemplated  thereby or any action taken or to be take pursuant thereto.  As of
the Closing Date, no action, suit, claim or proceeding before or by any court or
governmental  agency or body,  domestic or foreign,  shall be pending against or
affecting the Company, or any of its properties, which, if adversely determined,
is reasonably likely to result in a Material Adverse Effect.

                  (f) No  Material  Adverse  Effect  shall have  occurred  at or
before the Closing Date.

                  (g) The Company  shall have  delivered  on the Closing Date to
the Purchaser a secretary's certificate, dated as of the Closing Date, as to (i)
the  resolutions  of the  board of  directors  of the  Company  authorizing  the
transactions  contemplated by this Agreement,  (ii) the  Certificate,  (iii) the
Bylaws, each as in effect at the Closing,  and (iv) the authority and incumbency
of the officers of the Company executing this Agreement and the Note.

                                       -6-
<PAGE>

                  (h) The  Purchaser  shall  have  received  a legal  opinion in
substantially the form annexed hereto as Exhibit B as of the Closing Date.

         6. Legend. Each Note and certificate representing the Conversion Shares
shall be stamped  or  otherwise  imprinted  with a legend  substantially  in the
following  form  (in  addition  to  any  legend  required  by  applicable  state
securities or "blue sky" laws):

                  "THE   SECURITIES   REPRESENTED  BY  THIS   CERTIFICATE   (THE
                  "SECURITIES")  HAVE NOT BEEN  REGISTERED  UNDER THE SECURITIES
                  ACT OF 1933,  AS AMENDED (THE  "SECURITIES  ACT") OR ANY STATE
                  SECURITIES LAWS AND MAY NOT BE SOLD,  TRANSFERRED OR OTHERWISE
                  DISPOSED OF UNLESS  REGISTERED  UNDER THE  SECURITIES  ACT AND
                  UNDER  APPLICABLE  STATE  SECURITIES  LAWS  OR  MEDICAL  MEDIA
                  TELEVISION,  INC.  SHALL HAVE  RECEIVED  AN OPINION OF COUNSEL
                  THAT  REGISTRATION OF SUCH SECURITIES UNDER THE SECURITIES ACT
                  AND UNDER THE PROVISIONS OF APPLICABLE  STATE  SECURITIES LAWS
                  IS NOT REQUIRED."

The  Company  agrees  to  reissue  the Note and  certificates  representing  the
Conversion Shares,  without the legend set forth above if at such time, prior to
making any  transfer  of any such  Securities,  such holder  thereof  shall give
written  notice to the Company  describing the manner and terms of such transfer
and removal as the Company may reasonably  request.  Such proposed transfer will
not be effected until:  (a) the Company has notified such holder that either (i)
in the opinion of its counsel, the registration of the Note or Conversion Shares
under the  Securities  Act is not  required  in  connection  with such  proposed
transfer;  or (ii) a  registration  statement  under the Securities Act covering
such proposed  disposition has been filed by the Company with the Securities and
Exchange  Commission and has become  effective under the Securities Act; and (b)
the Company has  notified  such  holder that  either:  (i) in the opinion of its
counsel,  the registration or  qualification  under the securities or "blue sky"
laws of any state is not required in connection with such proposed  disposition,
or (ii) compliance with applicable  state securities or "blue sky" laws has been
effected.  The Company  will use its best  efforts to respond to any such notice
from a holder within five (5) days. In the case of any proposed  transfer  under
this Section 6, the Company will use reasonable  efforts to comply with any such
applicable  state  securities  or  "blue  sky"  laws,  but  shall in no event be
required, in connection therewith,  to qualify to do business in any state where
it is not then  qualified or to take any action that would  subject it to tax or
to the general service of process in any state where it is not then subject. The
restrictions  on transfer  contained  in this Section 6 shall be in addition to,
and not by way of limitation of, any other restrictions on transfer contained in
any other section of this Agreement.

         7. Fees and Expenses. Each party shall pay its own fees and expenses of
its advisors,  counsel,  accountants  and other  experts,  if any, and all other
expenses,  incurred  by such party  incident  to the  negotiation,  preparation,
execution, delivery and performance of this Agreement.

         8. Indemnification.

                  (a) The Company  hereby  agrees to indemnify and hold harmless
the Purchaser and its officers, directors,  shareholders,  employees, agents and
attorneys  against  any  and  all  losses,  claims,  damages,   liabilities  and
reasonable  expenses  (collectively  "Claims")  incurred  by each such person in
connection  with  defending or  investigating  any such  Claims,  whether or not
resulting in any liability to such person,  to which any such indemnified  party
may become  subject,  insofar as such Claims  arise out of or are based upon any
breach of any  representation  or warranty or  agreement  made by the Company in
this Agreement.

                                       -7-
<PAGE>

                  (b) The Purchaser hereby agrees to indemnify and hold harmless
the Company and its officers,  directors,  shareholders,  employees,  agents and
attorneys against any and all losses, claims, damages,  liabilities and expenses
incurred by each such person in connection with defending or  investigating  any
such claims or  liabilities,  whether or not  resulting in any liability to such
person,  to which  any such  indemnified  party  may  become  subject  under the
Securities Act, or under any other statute, at common law or otherwise,  insofar
as such  Claims  arise  out of or are based  upon (i) any  untrue  statement  or
alleged  untrue  statement of a material  fact made by the  Purchaser,  (ii) any
omission or alleged omission of a material fact with respect to the Purchaser or
(iii) any  breach  of any  representation,  warranty  or  agreement  made by the
Purchaser in this Agreement.

         9.  Governing Law;  Consent to  Jurisdiction.  This Agreement  shall be
governed by and  interpreted in accordance with the laws of the State of Florida
without giving effect to the rules  governing the conflicts of laws. Each of the
parties  consents to the  exclusive  jurisdiction  of the Federal  courts  whose
districts  encompass any part of the County of Hillsborough  located in the City
of Tampa in connection  with any dispute arising under this Agreement and hereby
waives,  to the maximum extent  permitted by law, any  objection,  including any
objection based on forum non conveniens,  to the bringing of any such proceeding
in such  jurisdictions.  Each party  waives  its right to a trial by jury.  Each
party to this  Agreement  irrevocably  consents to the service of process in any
such  proceeding  by the mailing of copies  thereof by  registered  or certified
mail,  postage prepaid,  to such party at its address set forth herein.  Nothing
herein shall affect the right of any party to serve  process in any other manner
permitted by law.

         10.  Notices.  All notices  and other  communications  provided  for or
permitted hereunder shall be made in writing by hand delivery, express overnight
courier,  registered  first class mail, or telecopier  (provided that any notice
sent by  telecopier  shall be confirmed by other means  pursuant to this Section
10),  initially to the address set forth  below,  and  thereafter  at such other
address,  notice of which is given in  accordance  with the  provisions  of this
Section.

                  (a) if to the Company:

                      Medical Media Television, Inc.
                      8406 Benjamin Road, Suite C
                      Tampa, Florida 33634
                      Attention: Philip M. Cohen, President/Chief
                      Executive Officer
                      Tel. No.: (813) 888-7330
                      Fax No.:  (813) 888-7375

                      with a copy to:

                      Bush Ross Gardner Warren & Rudy, P.A.
                      220 S. Franklin St.
                      Tampa, FL  33601
                      Attn:  John N. Giordano
                      Tel. No.:  (813) 224-9255
                      Fax No.:  (813) 223-9620

                                       -8-
<PAGE>

                  (b) if to the Purchaser:

                      Gilbert B. Ross
                      17640 Vincennes St.
                      Northridge, California  91325
                      Tel. No.:  (818) 993-7480
                      Fax No.:  (818) 349-7918

All such  notices  and  communications  shall be deemed to have been duly given:
when delivered by hand, if personally  delivered;  when receipt is acknowledged,
if telecopied; or when actually received or refused if sent by other means.

         11.  Assignment.  Neither  party may assign,  sell,  or transfer to any
third  person  the  rights of such  party  hereunder;  provided,  however,  that
Purchaser  may  assign  his  rights  hereunder  to an  entity  wholly  owned and
controlled by Purchaser.

         12.  Entire  Agreement.   This  Agreement,   the  Note  and  any  other
Transaction  Document  constitute the entire  understanding and agreement of the
parties  with  respect to the subject  matter  hereof and  supersedes  all prior
and/or  contemporaneous oral or written proposals or agreements relating thereto
all of which  are  merged  herein.  This  Agreement  may not be  amended  or any
provision  hereof  waived in whole or in part,  except  by a  written  amendment
signed by both of the parties.

         13. Counterparts. This Agreement may be executed by facsimile signature
and in counterparts, each of which shall be deemed an original, but all of which
together shall constitute one and the same instrument.

                                  [End of page]

                                       -9-
<PAGE>

         IN WITNESS  WHEREOF,  the Company and Payee have executed and delivered
this Note  Purchase  Agreement as of July 26, 2006 with an effective  date as of
the date first written above.

                                 MEDICAL MEDIA TELEVISION, INC.

                                 By: /s/ Philip M. Cohen
                                     -------------------------------------------
                                      Name: Philip M. Cohen
                                      Title:  President and Chief Executive
                                              Officer

                                 PURCHASER:

                                 /s/ Gilbert B. Ross
                                 -----------------------------------------------
                                      Gilbert B. Ross

                                      -10-
<PAGE>

                                    EXHIBIT A
                                    ---------
                                  FORM OF NOTE

                                      -11-
<PAGE>

                                    EXHIBIT B
                                    ---------
                                 FORM OF OPINION

         1. The Company is a corporation duly incorporated, validly existing and
in good  standing  under the laws of the State of Florida and has the  requisite
corporate  power to own,  lease and operate its  properties  and assets,  and to
carry on its business as presently conducted. The Company is duly qualified as a
foreign corporation to do business and is in good standing in every jurisdiction
in which the failure to so qualify would have a Material Adverse Effect.

         2. The Company has the requisite corporate power and authority to enter
into and perform its obligations  under the  Transaction  Documents and to issue
the  Securities.  The execution,  delivery and  performance  of the  Transaction
Documents  by  the  Company  and  the  consummation  by it of  the  transactions
contemplated  thereby  have been duly and validly  authorized  by all  necessary
corporate  action and no further consent or  authorization of the Company or its
Board of  Directors  is  required.  The  Transaction  Documents  have  been duly
executed  and  delivered,  and the Note  has  been  duly  executed,  issued  and
delivered  by the Company and each  Transaction  Document  constitutes  a legal,
valid and binding obligation of the Company  enforceable  against the Company in
accordance with its respective  terms. The Conversion  Shares are not subject to
any preemptive rights under the Certificate of Incorporation or the Bylaws.

         3. The Note  has been  duly  authorized  and,  when  delivered  against
payment in full as provided in the Purchase  Agreement,  will be validly issued.
The Conversion Shares have been duly authorized for issuance, and when delivered
upon  conversion  or against  payment in full as provided  in the Note,  will be
validly issued, fully paid and nonassessable.

         4. The execution,  delivery and  performance of and compliance with the
terms of the Transaction Documents and the issuance of the Securities do not (a)
violate any provision of the Certificate of Incorporation or Bylaws,  (b) to our
knowledge,  after due inquiry,  conflict  with,  or  constitute a default (or an
event which with notice or lapse of time or both would become a default)  under,
or  give to  others  any  rights  of  termination,  amendment,  acceleration  or
cancellation of, any material  agreement,  mortgage,  deed of trust,  indenture,
note,  bond,  license,  lease  agreement,  instrument or obligation to which the
Company  is a party and which is known to us,  (c) to our  knowledge,  after due
inquiry,  create or impose a lien,  charge or encumbrance on any property of the
Company under any agreement or any  commitment  known to us to which the Company
is a party or by which the  Company  is bound or by which any of its  respective
properties  or assets are bound,  or (d) result in a violation  of any  Federal,
state, local or foreign statute, rule, regulation,  order, judgment,  injunction
or  decree  (including  Federal  and  state  securities  laws  and  regulations)
applicable  to the  Company or by which any  property or asset of the Company is
bound or  affected,  except,  in all cases  other than  violations  pursuant  to
clauses  (a)  and  (d)  above,  for  such  conflicts,   default,   terminations,
amendments,   acceleration,   cancellations   and   violations   as  would  not,
individually or in the aggregate, have a Material Adverse Effect.

         5. No consent, approval or authorization of or designation, declaration
or filing with any governmental authority on the part of the Company is required
under  Federal,  state or local law, rule or  regulation in connection  with the
valid execution,  delivery and performance of the Transaction Documents,  or the
offer, sale or issuance of the Note or the Conversion Shares.

                                      -12-
<PAGE>

         6. To our knowledge,  there is no action, suit, claim, investigation or
proceeding  pending or  threatened  against  the  Company  which  questions  the
validity of the Purchase Agreement or the transactions  contemplated  thereby or
any action  taken or to be taken  pursuant  thereto.  There is no action,  suit,
claim,  investigation or proceeding  pending,  or to our knowledge,  threatened,
against or involving  the Company or any of its  properties or assets and which,
if adversely  determined,  is reasonably  likely to result in a Material Adverse
Effect.  There are no  outstanding  orders,  judgments,  injunctions,  awards or
decrees of any court,  arbitrator or governmental or regulatory body against the
Company or any officers or directors of the Company in their capacities as such.

         7. Conditioned on the accuracy of the Purchaser's  representations  and
warranties contained in the Purchase Agreement,  the offer, issuance and sale of
the Note and the offer,  issuance and sale of the Conversion  Shares pursuant to
the  Purchase  Agreement  and the  Note,  as  applicable,  are  exempt  from the
registration requirements of the Securities Act of 1933, as amended.

                                      -13-
<PAGE>

                                   SCHEDULE 3j
                                   -----------

Medical Media Television, Inc. Capital Stock:

Common Stock:              Authorized Shares:           100,000,000 shares
                           Outstanding Shares:           20,971,299 shares
                           Par Value:                    $.0005

Preferred Stock:           Total Authorized Shares:     25,000,000 shares
                           Total Outstanding Shares:     4,303,959 shares
                           Par Value:                    Zero

Series A Zero Coupon Preferred Stock:     Authorized Shares:    1,682,044 shares
                                          Outstanding Shares:   1,682,044 shares

Series B Zero Coupon Preferred Stock:     Authorized Shares:    2,612,329 shares
                                          Outstanding Shares:   2,612,329 shares

Series C Zero Coupon Preferred Stock:     Authorized Shares:      400,000 shares
                                          Outstanding Shares:       8,627 shares

      OUTSTANDING OPTIONS, WARRANTS, AND OTHER RIGHTS TO ACQUIRE SHARES OF
                         MEDICAL MEDIA TELEVISION, INC.

Outstanding stock options to purchase 5,303 shares of common stock of MMTV.

Outstanding warrants to purchase 10,879,235 shares of common stock of MMTV.

Outstanding  Series A and Series B  preferred  shares  which will  convert  into
16,093,989 shares of common stock of MMTV.

Outstanding  Series C preferred  shares  (8,627)  which will convert into common
shares at a discount to market at time of conversion.

Outstanding  convertible  debentures which will convert into 6,987,952 shares of
common stock of MMTV. These convertible  debentures may be repaid in cash at the
option of the Company.

The above  calculations  do not include  any shares of Series C preferred  stock
that  may  be  issued  for  interest  payments  on  existing   convertible  debt
instruments that will be converted into common shares at a discount to market at
time of  conversion.  It also does not  include  any common  shares  that may be
issued for interest payments on existing convertible debt instruments.

                                      -14-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00109-of-00352.parquet"}]]